Gabapentin and Tambocor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gabapentin (gabapentin) and Tambocor (flecainide acetate). Common drug interactions include asthenia among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Gabapentin and Tambocor. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.

What is Tambocor?

Tambocor has active ingredients of flecainide acetate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 2,621 Tambocor users. Check the latest studies of Tambocor.



On Jul, 28, 2026

31 people who take Gabapentin and Tambocor together, and have interactions are studied.

Gabapentin and Tambocor drug interactions.

What are the common drug interactions of Gabapentin and Tambocor, by gender? *:

female:

  1. Asthenia (weakness)
  2. Hyperhidrosis (abnormally increased sweating)
  3. Drug intolerance (drug sensitivity)
  4. Neuropathy peripheral (surface nerve damage)
  5. Cerebral thrombosis (blood clot in brain)
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  8. Peripheral coldness
  9. Tooth extraction
  10. Tunnel vision (the loss of peripheral vision with retention of central vision)

male:

  1. Pneumonia
  2. Asthenia (weakness)
  3. Renal failure (kidney dysfunction)
  4. Abnormal dreams
  5. Adverse event
  6. Back injury
  7. Back pain
  8. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  9. Chest injury
  10. Chest pain

What are the common drug interactions of Gabapentin and Tambocor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Asthenia (weakness)
  2. Blood pressure increased
  3. Chest pain
  4. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  5. Dyspnoea (difficult or laboured respiration)
  6. Headache (pain in head)
  7. Hyperhidrosis (abnormally increased sweating)
  8. Mitral valve incompetence (inefficient heart valve)
  9. Neuropathy peripheral (surface nerve damage)
  10. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)

50-59:

  1. Cerebral thrombosis (blood clot in brain)
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Peripheral coldness
  5. Tooth extraction
  6. Tunnel vision (the loss of peripheral vision with retention of central vision)
  7. Muscle spasticity (tight or stiff muscles and an inability to control those muscles)

60+:

  1. Asthenia (weakness)
  2. Drug intolerance (drug sensitivity)
  3. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  4. Chest injury
  5. Chest pain
  6. Chronic kidney disease
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Constipation
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Dehydration (dryness resulting from the removal of water)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 25.81%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 25.81%
  3. Multiple Myeloma (cancer of the plasma cells): 4 people, 12.90%
  4. Intervertebral Disc Disorder (spinal disc disorder): 3 people, 9.68%
  5. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 6.45%
  6. Neuropathy Peripheral (surface nerve damage): 2 people, 6.45%
  7. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 2 people, 6.45%
  8. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 6.45%
  9. High Blood Pressure: 2 people, 6.45%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Tambocor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gabapentin and Tambocor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tambocor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gabapentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tambocor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on gabapentin and flecainide acetate (the active ingredients of Gabapentin and Tambocor, respectively), and Gabapentin and Tambocor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: